Evonik process to be used in HPPO plant in China

Dr Dahai Yu, Member of the Executive Board, Evonik Industries AG.

• Evonik strengthens its relationship with Jilin Province
• License for Evonik-Uhde HPPO process signed

ESSEN, GERMANY: Evonik and representatives of the high ranking Chinese delegation delegation signed an agreement for a non-exclusive license to build and operate an hydrogen peroxide for propylene oxide (HPPO) plant at the Jilin site in Northeastern China. The license agreement will allow a yet-to-be-established joint venture between Jilin Shenhua and Jilin North Chemical Company (JNCC) to build a facility for the production of 300,000 metric ton of propylene oxide, which will operate on the basis of a process developed by Uhde and Evonik. 

“We’re pleased to have gained a partner in Jilin province for the attractive Chinese market. Our strength to develop new and innovative technologies is impressively documented by the second successful licensing of the HPPO procedure,” said Dr Yu, Member, Executive Board responsible for Asia, Evonik.

© WOC News